OAR@UM Collection:/library/oar/handle/123456789/1237912025-11-05T11:10:13Z2025-11-05T11:10:13ZEditorial : top research in MaltaDi Giovanni, Giuseppe/library/oar/handle/123456789/1237302024-06-18T09:23:42Z2023-01-01T00:00:00ZTitle: Editorial : top research in Malta
Authors: Di Giovanni, Giuseppe
Abstract: Dear Xjenza Online Readers,; Following the success of the inaugural Special Issue on Top Research in Malta, we have decided to
launch a new collection featuring researchers who were
among the top 2% of the most cited authors globally
in 2021. We were pleasantly surprised to see the inclusion of young colleagues alongside the distinguished
scholars from the previous edition. The 2021 top 2%
list was published by Stanford University and Elsevier and
is available at https://elsevier.digitalcommonsdata.com/
datasets/btchxktzyw/4.2023-01-01T00:00:00ZLiving in the era of multiple epidemics - a Malta perspectiveCuschieri, Sarah/library/oar/handle/123456789/1237292024-06-18T09:22:23Z2023-01-01T00:00:00ZTitle: Living in the era of multiple epidemics - a Malta perspective
Authors: Cuschieri, Sarah
Abstract: Non-communicable diseases (NCDs) have
long been a global epidemic way before the onset of the
COVID-19 pandemic. In 2016, it was estimated that
6.55% of the adult population in Malta suffered from at
least one NCD, with type 2 diabetes, obesity and low
back pain dominating the NCD scene. The onset of
COVID-19 challenged the healthcare systems, as well as
the wellbeing of the population. Restrictions instituted
to control COVID-19 led to negative repercussions on
those suffering from NCDs apart from bringing to the
fore specific NCDs such as mental illness, obesity, and
back pain. Furthermore COVID-19 increased the population burden through enhanced morbidity and mortality. However, the COVID-19 vaccination was observed
to have helped dampen this burden. Yet, it is important
that a syndemic approach is adopted to ensure that all epidemics are simultaneously given the appropriate attention
and timely action is provided to safeguard the population
health and wellbeing.2023-01-01T00:00:00ZClinical vaccine research on Meningococcal C disease in children in MaltaPace, David/library/oar/handle/123456789/1237282024-06-18T09:18:11Z2023-01-01T00:00:00ZTitle: Clinical vaccine research on Meningococcal C disease in children in Malta
Authors: Pace, David
Abstract: Clinical vaccine trials in children are extremely
important for the investigation of new vaccines as well as
for studying different ways of scheduling vaccines that are
currently in use. Data from such trials, in addition to epidemiological data on the infectious disease the vaccines
are trying to prevent, can be used to introduce vaccines
as well as to improve the current immunisation schedules.
The purpose of this review is to showcase the clinical vaccine research on meningococcal C vaccines in children that
was carried out in Malta in collaboration with the UK from
2010 to 2013, data from which have already been presented and published in peer reviewed journals. This review
gives a synopsis of the immunogenicity of reduced dose
meningococcal C vaccine schedules in infants as well as
the immune kinetics of the antibodies induced following a
booster dose at 12 months of age. The practicality of the
study findings are discussed, including their relevance to
the meningococcal vaccines that were recently introduced
on the national immunisation schedule in Malta. Hopefully this research will encourage doctors to show interest
in leading future research in children in Malta with appropriate support from our clinical and academic institutions.2023-01-01T00:00:00ZCannabinoids for fibromyalgia : an updated systematic reviewScicluna, Jean ClaudeDi Giovanni, Giuseppe/library/oar/handle/123456789/1237262024-06-18T09:13:16Z2023-01-01T00:00:00ZTitle: Cannabinoids for fibromyalgia : an updated systematic review
Authors: Scicluna, Jean Claude; Di Giovanni, Giuseppe
Abstract: Fibromyalgia is an increasingly prevalent condition resulting in high morbidity and economic burden for
sufferers. Minimal to modest benefit has been achieved by
pharmacotherapies, creating a strong rationale for novel
therapies. Substantial evidence has implicated the endocannabinoid system in the modulation of fibromyalgia
symptoms. However, the therapeutic potential and potential adverse effects of cannabis-based therapy in fibromyalgia are still under-reported, leading to clinicians’ hesitation
to opt for such therapy. This systematic review examined
the literature and provided a critical review of the safety
and efficacy of cannabis-based therapy in fibromyalgia.
It resulted that medical cannabis is a safe and effective
treatment option for fibromyalgia, whilst further research
in this area is needed.2023-01-01T00:00:00Z